Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Plerixafor Injection

Approval Number

国药准字H20223309

Company湖南五洲通药业股份有限公司

Registration Date

May 10, 2022

Drug Information

Generic Name

普乐沙福注射液

Dosage Form

注射剂

Strength

1.2ml:24mg

Drug Type

化学药品

Registration Date

May 10, 2022

Company Information

Applicant Company

Company Name湖南五洲通药业股份有限公司

Company Address

湖南省湘潭天易经开区碧泉潭路219号

Manufacturing Company

Company Name湖南五洲通药业股份有限公司

Company Address

湖南省湘潭天易经开区碧泉潭路219号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

普乐沙福注射液 - NMPA 批准文号 | MedPath